Unlocking the $1 Trillion Potential of Women's Brains

Investing in womens brain health could add one trillion dollars to global GDP each year. Addressing gender gaps in research, workplace support, and healthcare not only improves wellbeing but also boosts productivity and economic resilience worldwide.

The global economic consequences of neglecting women's health are most pronounced in the area of brain health, where the costs are substantial yet largely preventable. Closing the gender health gap could contribute an estimated $1 trillion to annual global GDP, positioning women's health as a critical factor in macroeconomic strategy and decision-making for both public institutions and private enterprises.

Historically, women's health has been insufficiently recognized as a driver of economic productivity. Recent developments, including the inaugural National Conference on Women's Health hosted by the U.S. Department of Health and Human Services, signal a growing policy focus on addressing women's health challenges systematically and with urgency. Despite longer life expectancy, women experience roughly 25% more years of poor health than men, which negatively affects labor force participation, household economic stability, and the resilience of healthcare systems.

Brain Health as a Priority

Brain health is a central determinant of these outcomes and represents a crucial entry point for interventions. Effective strategies focus on three main areas:

• Research funding organizations should mandate sex-disaggregated data collection and prioritize women-focused clinical trials for brain-related conditions.
• Employers should expand workplace benefits to encompass menopause support and programs promoting cognitive wellness.
• Policymakers should integrate women's brain health into frameworks for workforce productivity and the sustainability of healthcare systems.

Alzheimer’s Disease and Gender Disparities

Women bear a disproportionate burden of Alzheimer's disease. Approximately two-thirds of Americans living with Alzheimer's are women, and over 60% of caregivers are also women, often during peak professional years and frequently without financial compensation. The associated economic impact in the United States reaches an estimated $781 billion annually, divided into $232 billion in medical and long-term care, $233 billion in unpaid caregiving labor, and 6.8 billion hours of unpaid work not reflected in GDP. Families cover roughly 70% of lifetime dementia care expenses. The dual challenge of elevated disease risk and caregiving responsibilities reduces workforce participation, strains household finances, and places additional pressure on public health systems. Modeling suggests that cutting Alzheimer's risk in women by 50% could save the U.S. approximately $4.56 trillion.

Wider Implications for Productivity and Mental Health

Beyond Alzheimer’s, women of working age face higher incidences of depression, anxiety, and cognitive challenges linked to menopause. These conditions contribute to absenteeism, reduced productivity, and workforce turnover. Economic analyses indicate that lowering the global burden of depression could raise GDP by up to $230 billion, while reducing anxiety disorders could contribute roughly $169 billion. Menopause, a neurological transition affecting brain structure, connectivity, and energy metabolism, further impacts cognitive performance and mood. Untreated menopause symptoms in the U.S. are estimated to cost $26.6 billion annually, yet only 21% of employers provide menopause-specific benefits. Workforce disruptions and employee replacement costs, ranging from 40% to 200% of annual salary, further amplify economic losses when brain health is not addressed.

Structural Barriers in Research and Investment

Underinvestment in women's brain health stems from a historical pattern in medical research and funding. Male physiology has often been used as the default in clinical studies, leaving significant evidence gaps for women. This contributes to:

• Higher perceived investment risk for under-researched conditions
• Reduced funding allocation
• Slower scientific and clinical advancements
• Reinforcement of continued underinvestment

Currently, only 6% of private healthcare investment targets women's health, with most funding directed toward reproductive health, maternal care, and cancer. Conditions such as Alzheimer’s and menopause remain significantly underfunded. Addressing four underserved women-specific therapeutic areas in the U.S. alone could represent a market exceeding $100 billion by 2030.

Conclusion: Scalable Economic Opportunity

Evidence demonstrates that women's brain health constitutes both a significant economic burden and a substantial opportunity for growth. The projected $1 trillion annual global GDP gain underscores the potential improvements achievable if systemic gaps in research, workplace policies, and healthcare investment are addressed. This opportunity is not due to a lack of value but results from structural limitations in health data management and investment priorities. Prioritizing women's brain health as a core economic and healthcare concern could unlock measurable benefits across productivity, healthcare sustainability, and long-term economic performance.

Sources:

• Women’s Brains Are a $1 Trillion Opportunity